Xiuchun Chen
Overview
Explore the profile of Xiuchun Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiao D, Chen X, Sun X, Lu Z, Dai H, Wang C, et al.
BMC Cancer
. 2025 Feb;
25(1):209.
PMID: 39915736
Purpose: An earlier multicenter phase III study demonstrated the safety and efficacy of mitoxantrone hydrochloride injection for tracing (MHI) for detecting sentinel lymph nodes (SLNs) in breast cancer patients. This...
2.
Ma Y, Zhang J, Jiao D, Chen X, Liu Z
Cancer Med
. 2024 Dec;
13(24):e70484.
PMID: 39704402
Purpose: Few studies with a large sample size are available on patients with metabolic syndrome (MetS) receiving neoadjuvant treatment (NAT) for breast cancer. This study aimed to investigate the impact...
3.
Zhang L, Chen X, Du N
Glob Pediatr Health
. 2024 Nov;
11:2333794X241290364.
PMID: 39525951
. Case management, which is defined as a fully collaborative process that includes evaluation, planning, execution, coordination and supervision, has been widely used in the field of chronic diseases. However,...
4.
Yan M, Ouyang Q, Sun T, Niu L, Yang J, Li L, et al.
EClinicalMedicine
. 2024 Oct;
76:102837.
PMID: 39380967
Background: The phase 2 PERMEATE study has shown the antitumor activity and safety of pyrotinib plus capecitabine in patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer...
5.
Chen X, Lu Z, Wang C, Lyu M, Qiao J, Sun X, et al.
Chin Med J (Engl)
. 2024 Apr;
137(12):1421-1430.
PMID: 38557731
Background: Sentinel lymph node (SLN) biopsy is gradually accepted as the standard of care in breast cancer patients with down-staged axillary disease after neoadjuvant chemotherapy (NAC). However, it is still...
6.
Zhu Q, Liu C, Bai B, Pei F, Tang Y, Song W, et al.
BMC Oral Health
. 2024 Mar;
24(1):294.
PMID: 38431556
Background: The preparation of the middle mesial (MM) canal of mandibular molars represents a challenge because it is often curved, narrow, and close to the root concave. The purpose of...
7.
Wang C, Liu Z, Chen X, Qiao J, Lu Z, Li L, et al.
Nat Commun
. 2023 Oct;
14(1):6654.
PMID: 37863916
Immunotherapy combined with chemotherapy has been demonstrated to be effective in early triple-negative breast cancer (TNBC). In this single-arm, phase II study with Simon's two-stage design, we investigated the efficacy...
8.
Yan M, Niu L, Lv H, Zhang M, Wang J, Liu Z, et al.
Nat Commun
. 2023 Oct;
14(1):6272.
PMID: 37805496
CDK4/6 inhibitors have shown a synergistic effect with anti-HER2 therapy in hormone receptor (HR)-positive and HER2-positive breast cancer (BC). In this phase 2 study (NCT04293276), we aim to evaluate a...
9.
Ma Y, Jiao D, Zhang J, Lv M, Chen X, Liu Z
Oncologist
. 2023 Sep;
29(3):e309-e318.
PMID: 37769330
Background: Based on the association between the hormone receptor and the status of human epidermal growth factor receptor 2 (HER2)-low, we investigated the clinicopathological and prognostic characteristics of the HER2-low...
10.
Yang H, Sun Y, Wang P, Qiao J, Li L, Lu Z, et al.
Med Sci Monit
. 2023 Jul;
29:e940124.
PMID: 37454245
BACKGROUND The efficacy of abemaciclib in high-risk patients with early-stage HR+/Her2- breast cancer has been verified by MonarchE. However, accurately determining the number of axillary lymph node (ALN) metastases remains...